Card image cap

Richard Blumenthal's Public Statements on Issue: Drugs

Office:
Page 1 of 4

Date Title
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
08/06/2021 Letter to the Honorable Merrick Garland, Attorney General - Warren, Blumenthal, Maloney, and DeSaulnier Urge DOJ to Immediately Appeal Purdue Pharma's Bankruptcy Plan that Would Shield Sackler Family from Accountability for Opioid Crisis
07/26/2021 Letter to Hon. Robert Drain, New York District Judge - Senator Hassan, Colleagues Oppose Purdue Pharma's Request for Bonuses to Top Executives & Employees Amid Ongoing Opioid Epidemic
04/19/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Senator Markey Leads Colleagues in Urging Fda to Ban Menthol Cigarettes
04/16/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Feinstein, Markey, Colleagues Urge FDA to Ban Menthol Cigarettes
03/15/2021 Letter to Honorable Merrick Garland, Attorney General - Schatz, Blumenthal Urge Attorney General To Investigate McKinsey's Role In Fueling Opioid Epidemic
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/16/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
01/28/2020 Letter to the Hon. Sonny Perdue, Secretary of the U.S. Dept. of Agriculture, and the Hon. Bruce Summers, Admin. of the Agricultural Marketing Service - Commissioner Bryan Hurlburt And Rep. Joe Courtney Lead Connecticut Congressional Delegation To Urge Changes On USDA's Hemp Production Rules
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
10/29/2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
10/31/2018 Letter to the Hon. Scott Gottlieb, Comissioner of the Food and Drug Administration - Senators Blast FDA Decision to Approve New Supercharged Opioid Dsuvia
10/29/2018 Letter to the Hon. Scott Gottlieb, Comissioner of the Food and Drug Administration - Wyden, Durbin, Murray & Colleagues Urge FDA to Protect Kids from Tobacco Use and Addiction
07/06/2018 Letter to the Centers for Disease Control and Prevention - Senators Call on CDC to better Support Forensic Medicine as Overdose Deaths Continue to Rise
04/18/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
03/08/2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
03/05/2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
03/02/2018 Letter to Aetna, AHIP, Anthem, BCBS, CareSource, Centene, Cigna, Humana, Kaiser, Molina, and UnitedHealth - Step Up Response to Opioid Epidemic

Page 1 of 4
arrow_upward